pharmacology 2 Flashcards

1
Q

what is the importance of clinical trials

A

they provide evidence for evaluation and sign guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

examples of drug treatment that is based on trial evidence

A

treatment for myocardial infarction
treatment for stroke
treatment for cancer
treatment for rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

factors to consider when making a drug

A

whether it works
the dose that is therapeutic
toxic dose
safe dose
whether or not it is necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

reasons for conducting clinical trials

A

what works in theory might not work best in practise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what body regulates clinical trials

A

MHRA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is tested when checking on clinical trials

A

safety
efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

aspects of efficacy that are tested on

A

compared with placebo
compared with another drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

stages in the development of a drug

A

drug discovery
preclinical development
clinical development
tegenero drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

phase 1 clinical development

A

volunteer are given the drug and there is also some that are given on a placebo effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

phase 2 of drug development

A

this occurs after the the volunteers have been found to be healthy , and it is given to confirm the kinetics and dynamics in patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how many people are involved in phase 2 clinical development

A

upto 500 patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

phase 3 clinical development

A

formal therapeutic trials where effective and they are established and the evidence of safety is obtained.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how many people involved in phase 3 clinical development

A

upto 10000 patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

phase 4 clinical development

A

includes post marketing surveillance which produces evidence of long term safety .
involves tens or hundreds patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

examples of clinical trials

A

double blind
single blind
prospective
retrospective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

factors to be considered during pre clinical development

A

animal pharmacology
animal toxicology
tissue culture

17
Q

factors under animal pharmacology

A

dose
adverse effects

18
Q

factors under toxicology

A

fertility
teratogenicity ‘
mutagenicity

19
Q

drugs that bypass phase 1 clinical development

A

. cytotoxics will bypass this phase

example chemotherapy

20
Q

what are the factors being tested on in phase 11 clinical development

A

pharmacokinetics and pharmacodynamics

21
Q

factors being considered in phase 2 clinical trials

A

evidence of efficacy
likely dosage range

22
Q

phase 4

A

-post marketing surveillance to produce evidence of long term safety
-may involve tens or hundreds of patients .

23
Q

methods of controlled study

A

placebo controlled study
comparison with other therapy
cross over design
randomised control clinical trial where the patients are assigned at random to either treatments or control.

24
Q

disadvantages of control trial

A

generalizable results
recruitment
acceptability of randomization process
administrative complexity of randomised methods

25
what are the commonly used phase 3 designs
Parallel Withdrawal Group/Cluster Randomized Consent Cross Over Factorial Large Simple Equivalence/Non-inferiority Sequential
26
superiority trials
Show that new treatment is better than the control or standard (maybe a placebo)
27
non-inferiority
Is not worse that the standard by more than some margin Would have beaten placebo if a placebo arm had been included (regulatory)
28
how to design a study
hypothesis endpoints number of subjects safety endpoints
29
exclusion and selection criteria
Exclude pregnant women Children Seriously ill patients ? Elderly patients Patients at risk of side effects
30
challenges in conducting studies
declining renal function multiple morbidities
31
analysis of a study
p of 0.05 is usually taken as significance choose statistical test
32
interpreting an insignificant study
33
what is a significance of a test
whether or not they were by chance or there is an association
34
interpreting an insignificant finding
No difference or just that the study hasn’t found one? Two treatments may be clinically equivalent
35
ethical factors to consider when conducting a study
Consent Ethics committee Placebos Children Study design ‘Policing’ studies
36
what are the aims of a good clinical trial
Protect the public Provide evidence to help rational prescribing
37